213 related articles for article (PubMed ID: 21772295)
1. Mycophenolate mofetil monitoring: is there evidence that it can improve outcomes?
Byrne R; Yost SE; Kaplan B
Clin Pharmacol Ther; 2011 Aug; 90(2):204-6. PubMed ID: 21772295
[No Abstract] [Full Text] [Related]
2. Therapeutic drug monitoring for mycophenolic acid is value for (little) money.
van Gelder T
Clin Pharmacol Ther; 2011 Aug; 90(2):203-4. PubMed ID: 21772294
[No Abstract] [Full Text] [Related]
3. Mycophenolate mofetil for transplantation: new drug, old problems?
Gray DW
Lancet; 1995 Aug; 346(8972):390. PubMed ID: 7623565
[No Abstract] [Full Text] [Related]
4. Pharmacology and toxicology of mycophenolate in organ transplant recipients: an update.
Staatz CE; Tett SE
Arch Toxicol; 2014 Jul; 88(7):1351-89. PubMed ID: 24792322
[TBL] [Abstract][Full Text] [Related]
5. Therapeutic drug monitoring of mycophenolate mofetil in transplantation.
van Gelder T; Le Meur Y; Shaw LM; Oellerich M; DeNofrio D; Holt C; Holt DW; Kaplan B; Kuypers D; Meiser B; Toenshoff B; Mamelok RD
Ther Drug Monit; 2006 Apr; 28(2):145-54. PubMed ID: 16628123
[TBL] [Abstract][Full Text] [Related]
6. Therapeutic drug monitoring of mycophenolates: why make simple things complicated?
Kuypers DR; van Gelder T
Transplant Rev (Orlando); 2011 Apr; 25(2):45-6. PubMed ID: 21477747
[No Abstract] [Full Text] [Related]
7. Opportunities for therapeutic monitoring of mycophenolate mofetil dose in renal transplantation suggested by the pharmacokinetic/pharmacodynamic relationship for mycophenolic acid and suppression of rejection.
Nicholls AJ
Clin Biochem; 1998 Jul; 31(5):329-33. PubMed ID: 9721430
[No Abstract] [Full Text] [Related]
8. Therapeutic drug monitoring of mycophenolic acid in solid organ transplant patients treated with mycophenolate mofetil: review of the literature.
Arns W; Cibrik DM; Walker RG; Mourad G; Budde K; Mueller EA; Vincenti F
Transplantation; 2006 Oct; 82(8):1004-12. PubMed ID: 17060847
[TBL] [Abstract][Full Text] [Related]
9. [Mycophenolate mofetil, a possible new immunosuppresant].
Weberová J; Voboril R; Semecký V
Ceska Slov Farm; 2002 Sep; 51(5):220-5. PubMed ID: 12407919
[TBL] [Abstract][Full Text] [Related]
10. Therapeutic monitoring of mycophenolate mofetil.
Jeong H; Kaplan B
Clin J Am Soc Nephrol; 2007 Jan; 2(1):184-91. PubMed ID: 17699403
[No Abstract] [Full Text] [Related]
11. Monitoring of mycophenolic acid in clinical transplantation.
Shaw LM; Pawinski T; Korecka M; Nawrocki A
Ther Drug Monit; 2002 Feb; 24(1):68-73. PubMed ID: 11805725
[No Abstract] [Full Text] [Related]
12. Mycophenolate mofetil--a new immunosuppressant for organ transplantation.
Med Lett Drugs Ther; 1995 Sep; 37(958):84-6. PubMed ID: 7674993
[No Abstract] [Full Text] [Related]
13. Therapeutic monitoring of mycophenolate mofetil in organ transplant recipients: is it necessary?
Mourad M; Wallemacq P; König J; de Frahan EH; Eddour DC; De Meyer M; Malaise J; Squifflet JP
Clin Pharmacokinet; 2002; 41(5):319-27. PubMed ID: 12036390
[TBL] [Abstract][Full Text] [Related]
14. Mycophenolate mofetil-based immunosuppressive minimization and withdrawal strategies in renal transplantation: possible risks and benefits.
Meier-Kriesche HU
Curr Opin Nephrol Hypertens; 2006 Jun; 15 Suppl 1():S1-5. PubMed ID: 16829733
[TBL] [Abstract][Full Text] [Related]
15. Sirolimus and mycophenolate as combination prophylaxis in corneal transplant recipients at high rejection risk.
Chatel MA; Larkin DF
Am J Ophthalmol; 2010 Aug; 150(2):179-84. PubMed ID: 20570235
[TBL] [Abstract][Full Text] [Related]
16. Mycophenolate mofetil, Cellcept, a new immunosuppressive drug with great potential in internal medicine.
Smak Gregoor PJ; van Gelder T; Weimar W
Neth J Med; 2000 Dec; 57(6):233-46. PubMed ID: 11099793
[TBL] [Abstract][Full Text] [Related]
17. Trough blood concentrations in long-term treatment with mycophenolate mofetil.
Sanquer S; Breil M; Baron C; Dahmane D; Astier A; Lang P
Lancet; 1998 May; 351(9115):1557. PubMed ID: 10326544
[No Abstract] [Full Text] [Related]
18. Pharmacodynamic monitoring of immunosuppressive drugs.
Yatscoff RW; Langman LJ; LeGatt DF
Transplant Proc; 1996 Dec; 28(6):3013-5. PubMed ID: 8962169
[No Abstract] [Full Text] [Related]
19. The case of azathioprine versus mycophenolate. Do different drugs really cause different transplant outcomes?
Craig JC; Webster AC; McDonald SP
Transplantation; 2009 Mar; 87(6):803-4. PubMed ID: 19300180
[No Abstract] [Full Text] [Related]
20. Therapeutic drug level monitoring for mycophenolate mofetil: is it justified?
Stephan A; Masri MA; Barbari A; Kamel G; Karam A; Kilani H
Transplant Proc; 2001 Aug; 33(5):2778-9. PubMed ID: 11498157
[No Abstract] [Full Text] [Related]
[Next] [New Search]
